Overview

Cell Expansion Market Introduction

Cell Expansion Market is predicted to value over USD 27.4 billion by 2027 end and record a CAGR of over 15.1% during the forecast period 2020 to 2027. 

The consumables segment is leading the market. The prominent factor that has resulted into this escalating global cell expansion market growth is its substantial rise in the number of screenings offering a high throughput, which in turn, increases the usage of consumables throughout the new drug discovery stage. The disposables are predicted to record a faster growth rate over the forecast period owing to the negligible risk related to the cross-contamination of the equipment used in the laboratory and thriving pharmaceutical and biotechnology industry.

Regenerative medicine segment is predicted to dominate the market during the forecast period. There have been advancements in technology in the translational research over the last two decades that are related to tissue engineering and molecular biology that is used in regenerative medicine. It makes sure that the normal cellular activities of internal organs of the human body are properly restored. The clinical diagnostics are garnering the attention of researchers across the world due to advancements made into the companion diagnostic kit technology and rising awareness regarding public health thus resulting in early chronic ailment screenings.

The North America region, with a market share of over 30%, is subjugating the cell expansion market. The prominent factors contributing to the augmentation of the market in the region are increasing incidences of persistent diseases and rising demand for regenerative medicines. According to the research cited by the National Health Council of CDC, over 130 million American citizens are diagnosed with adverse ailments. The European region holds over 25% market share mainly owing to the prevalence of key players such as GE Healthcare, Becton Dickinson & Company Merck Millipore, etc. The Asia Pacific region currently holds over 15% market share owing to a constantly developing infrastructure for healthcare and regulatory environment that is in favour of the local healthcare agencies in the region.

Key market players are:

Thermo Fisher Scientific Inc., Terumo BCT, Merck KGaA, Beckman Coulter Inc., Miltenyi Biotec, Lonza Group Ltd., Stemcell Technologies Inc., GE Healthcare, Corning Inc.

Cell Expansion Market Segmentation:

By Product 

• Consumables
• Media
• Reagents
• Sera
• Disposables
• Tissue Culture Flasks
• Bioreactor Accessories
• Other Disposables
• Instruments
• Cell Expansion Supporting Equipment 
• Flow Cytometers
• Centrifuges
• Cell Counters & Haemocytometers
• Other Supporting Equipment 
• Bioreactors
• Microcarrier Bioreactor
• Microcarrier-Based Anchorage-Dependent Bioreactors
• Suspension-Based Anchorage-Independent Bioreactors
• Perfusion/Hollow Fiber Bioreactors
• Automated Cell Expansion Systems

By Cell Type

• Human Cells
• Stem Cells
• Adult Stem Cells
• Induced Pluripotent Stem Cells (IPSCs)
• Embryonic Stem Cells (ESCs)
• Differentiated Cells
• Animal Cells

By Application

• Regenerative Medicine and Stem Cell Research
• Cancer and Cell-Based Research
• Other Applications

By End User

• Biotechnology & Biopharmaceutical Companies
• Research Institutes
• Cell Banks
• Other End Users

By Region

• North America
• Europe
• Asia Pacific
• Rest of the World

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis 
• Key trends 
• Key data-points affecting market growth 

Objectives of the Study:

• To provide with an exhaustive analysis on the global cell expansion market by product, by cell type, by application, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market 
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and the rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents

1 Introduction 

1.1 Objectives of the Study 

1.2 Market Definition 

        1.2.1 Markets Covered

        1.2.2 Country Coverage

        1.2.3 Years Considered for the Study

1.3 Currency 

1.4 Limitations 

1.5 Stakeholders 

 

2 Research Methodology 

2.1 Secondary Data 

        2.1.1 Key Data From Secondary Sources

2.2 Primary Data 

        2.2.1 Key Data From Primary Sources

2.3 Market Size Estimation 

        2.3.1 Bottom-Up Approach

        2.3.2 Top-Down Approach

2.4 Market Breakdown and Data Triangulation 

2.5 Assumptions for the Study 

3 Executive Summary 

    3.1 Market Outlook

    3.2 Segment Outlook

    3.3 Competitive Insights

4 Premium Insights 

4.1 Market: Market Overview 

4.2 North America: Market, By Product (2020)

4.3 Geographical Snapshot of the Market 

 

5 Market Overview

5.1 Introduction 

5.2 Market Dynamics 

        5.2.1 Drivers

                 5.2.1.1 Increasing Incidence of Chronic Diseases

                 5.2.1.2 Government Investments for Cell-Based Research

                 5.2.1.3 Growing Focus on Personalized Medicine

                 5.2.1.4 Increasing Focus on R&D for Cell-Based Therapies

                 5.2.1.5 Increasing GMP Certifications for Cell Therapy Production Facilities

        5.2.2 Restraints

                 5.2.2.1 Ethical Concerns Regarding Research in Cell Biology

        5.2.3 Opportunities

                 5.2.3.1 Emerging Markets

                 5.2.3.2 3D Cell Expansion Technology

 

6 Cell Expansion Market, By Product 

6.1 Introduction 

6.2 Consumables 

        6.2.1 Media

                 6.2.1.1 Media Segment to Dominate the Cell Expansion Consumables Market

        6.2.2 Reagents

                 6.2.2.1 Reagents Segment to Account for the Second-Largest Share of the Cell Expansion Consumables Market

        6.2.3 Sera

                 6.2.3.1 North America to Dominate the Cell Expansion Sera Market

        6.2.4 Disposables

                 6.2.4.1 Tissue Culture Flasks

                            6.2.4.1.1 Tissue Culture Flasks Segment Accounted for the Largest Share of the Disposables Market

                 6.2.4.2 Bioreactor Accessories

                            6.2.4.2.1 Bioreactor Accessories Segment Accounted for the Second-Largest Share of the Disposables Market

                 6.2.4.3 Other Disposables

6.3 Instruments 

        6.3.1 Cell Expansion Supporting Equipment

                 6.3.1.1 Flow Cytometers

                            6.3.1.1.1 Product Launches to Drive the Growth of This Market Segment

                 6.3.1.2 Centrifuges

                            6.3.1.2.1 Major Players are Focusing on Launching New and Advanced Centrifuges in the Market

                 6.3.1.3 Cell Counters & Hemocytometers

                            6.3.1.3.1 Technological Advancements Supporting the Growth of the Cell Counters & Hemocytometers Market

                 6.3.1.4 Other Supporting Equipment

        6.3.2 Bioreactors

                 6.3.2.1 Microcarrier Bioreactors

                            6.3.2.1.1 Microcarrier-Based Anchorage-Dependent Bioreactors

                                          6.3.2.1.1.1 Microcarrier-Based Anchorage-Dependent Bioreactors Offer Large-Scale Production

                            6.3.2.1.2 Suspension-Based Anchorage-Independent Bioreactors

                                          6.3.2.1.2.1 North America is the Largest Market for Suspension-Based Anchorage-Independent Bioreactors

                 6.3.2.2 Perfusion/Hollow Fiber Bioreactors

                            6.3.2.2.1 Collaborations and Product Launches Supporting the Growth of This Market Segment

        6.3.3 Automated Cell Expansion Systems

                 6.3.3.1 Technological Advancements to Drive the Growth of This Market Segment

 

7 Cell Expansion Market, By Cell Type 

7.1 Introduction 

7.2 Human Cells 

        7.2.1 Stem Cells

                 7.2.1.1 Adult Stem Cells

                            7.2.1.1.1 Adult Stem Cells Segment Accounts for the Largest Share of the Human Stem Cells Market, Primarily Due to Increased Government Initiatives in Cell-Based Research

                 7.2.1.2 Induced Pluripotent Stem Cells (IPSCS)

                            7.2.1.2.1 IPSCS are Sued in Cell Replacement Therapies, Drug Screening, and Tissue Regeneration

                 7.2.1.3 Embryonic Stem Cells (ESCS)

                            7.2.1.3.1 Increasing Private and Public Investments for Stem Cell Research—Major Factor Driving Market Growth

        7.2.2 Differentiated Cells

                 7.2.2.1 Increasing Prevalence of Cancer is the Major Factor Driving the Growth of This Market

7.3 Animal Cells 

        7.3.1 Biopharmaceutical Companies are the Major End Users of Animal Cells

 

8 Cell Expansion Market, By Application 

8.1 Introduction 

8.2 Regenerative Medicine and Stem Cell Research 

        8.2.1 Increasing Government Funding on Regenerative Medicine and Stem Cell Research to Drive Market Growth

8.3 Cancer and Cell-Based Research 

        8.3.1 Increasing Prevalence of Cancer to Support Market Growth

8.4 Other Applications 

 

9 Cell Expansion Market, By End User 

9.1 Introduction 

9.2 Biotechnology & Biopharmaceutical Companies 

        9.2.1 Increasing Investments in Cell-Based Research to Drive Market Growth

9.3 Research Institutes 

        9.3.1 Growth in Funding for Life Science Research to Drive the Market for Research Institutes

9.4 Cell Banks 

        9.4.1 Increasing Awareness Among People About the Benefits of Preserving Stem Cells to Drive Market Growth

9.5 Other End Users 

 

10 Cell Expansion Market, By Region 

  10.1 Introduction 

  10.2 North America 

          10.2.1 US

                     10.2.1.1 US to Witness the Highest Growth in the North American Market Due to the Increasing Government Funding on Cell-Based Research

          10.2.2 Canada

                     10.2.2.1 Increasing Funding for Research in Regenerative Medicine to Support Market Growth in Canada

  10.3 Europe 

          10.3.1 Germany

                     10.3.1.1 Germany is the Fastest-Growing Market for Cell Expansion in Europe

          10.3.2 France

                     10.3.2.1 Robust Biotechnology Infrastructure in the Country to Support Market Growth

          10.3.3 UK

                     10.3.3.1 Government Investments in Stem Cell Research to Drive the Market for Cell Expansion in the UK

          10.3.4 Italy

                     10.3.4.1 Increasing Number of Cell Biology Seminars and Conferences to Fuel the Adoption of Cell Expansion Products

          10.3.5 Spain

                     10.3.5.1 Increasing Funding From Private and Public Organizations to Aid Market Growth

          10.3.6 Rest of Europe (RoE)

  10.4 Asia Pacific 

          10.4.1 Japan

                     10.4.1.1 Growing Geriatric Population in the Country to Drive Market Growth

          10.4.2 China

                     10.4.2.1 Government Initiatives to Promote Stem Cell Research to Play A Major Role in Driving Market Growth

          10.4.3 India

                     10.4.3.1 Growing Pharmaceutical and Biotechnology Industries—Key Growth Driver for the Market in India

          10.4.4 Singapore

                     10.4.4.1 Presence of Leading Pharmaceutical Companies is Supporting the Growth of the Market in the Country

          10.4.5 South Korea

                     10.4.5.1 Conferences and Research Activities on Stem Cells are Supporting the Growth of the Market in the Country

          10.4.6 Rest of Asia Pacific

  10.5 RoW 

          10.5.1 Latin America

                     10.5.1.1 Increasing Incidence of Cancer to Drive the Market for Cell Expansion

          10.5.2 Middle East & Africa

 

11 Competitive Landscape 

  11.1 Overview 

  11.2 Market Share Analysis, 2018 

  11.3 Competitive Scenario 

          11.3.1 Product Launches and Approvals, 2017–2020

          11.3.2 Acquisitions, 2017–2020

          11.3.3 Agreements, 2017–2020

          11.3.4 Expansions, 2017–2020

  11.4 Competitive Leadership Mapping (2019) 

          11.4.1 Vendor Inclusion Criteria

          11.4.2 Visionary Leaders

          11.4.3 Innovators

          11.4.4 Dynamic Differentiators

          11.4.5 Emerging Companies

 

12 Company Profiles 

  12.1 Thermo Fisher Scientific, Inc. 

  12.2 Becton, Dickinson and Company 

  12.3 Terumo BCT 

  12.4 Merck KGaA 

  12.5 Beckman Coulter Inc. (Subsidiary of Danaher Corporation) 

  12.6 Miltenyi Biotec 

  12.7 Lonza Group Ltd. 

  12.8 Stemcell Technologies, Inc. 

  12.9 GE Healthcare 

  12.10 Corning Incorporated

 

Chapter 13 Research Finding and Conclusion 

 

Chapter 14  Research Methodology 

 

Chapter 15  Research Data Source   

 

Tables

Figures